Credit: S.Nersisyan et al. HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study...
Novavax has signed a memorandum of understanding (MOU) with the vaccine alliance, Gavi, to provide 1.1 billion doses of its recombinant protein-based COVID-19 vaccine, NVX-CoV2373, for...
A transcript of The Conversation Weekly podcast episode #3.
While some of the authorised COVID-19 vaccines are grown, others are built.
With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
The temporary suspensions affect the Phase I/II HGB-206 trial, an ongoing, open-label study designed to evaluate the efficacy and safety of LentiGlobin gene therapy for sickle...
Advocacy groups play a crucial role in both driving access to innovative treatment and services and educating patients The post Building early relationships: a gamechanger for...
WHO Issues 'Alert' To Six African Nations After Recent Ebola Outbreaks After the West African country of Guinea reported its first confirmed Ebola deaths since 2016,...
Operation Warp Speed’s former science chief Moncef Slaoui is to lead research at a new mega-biotech called Centessa,
Graphene based COVID tests are quick and robust.
German Nursing Home Whistleblower: "Elderly Dying After COVID Vaccine" Via 21stCenturyWire.com, Since the public release of the controversial mRNA vaccine, many disturbing reports of adverse reactions...
On Feb. 12, medical technology company Becton Dickinson & Co announced that it had received emergency use authorization (EUA) from the U.S. Food and Drug Administration...
We mapped the genes of B cells to better understand why some develop immunity and others don't.
How the UK came to be the world leader in sequencing SARS-CoV-2, in the words of the person who made it all happen.
How the UK came to be the world leader in sequencing SARS-CoV-2, in the words of the person who made it all happen.
The arrival of COVID-19 vaccines has raised hope for an end to the pandemic. Hopefully that's true, but there are variables. Here are some factors that...
Mate Fertility, the new Los Angeles startup launching today with $2.8 million in financing, has a mission to create a more inclusive network of family planning...
CNBC Transcript: Johnson & Johnson Chairman & CEO Alex Gorsky speaks with Meg Tirrell live during CNBC’s Healthy Returns Spotlight today on the company’s one-shot coronavirus...
Credit: ETH Zurich /Giulia Marthaler Scientific and public health experts have been raising the alarm for decades, imploring public officials to prepare for the inevitability of...
When the pandemic heated up early last year, the UK Biobank set out to urgently gather data on COVID-19 diagnostic tests, deaths, and hospitals episodes, such...
Despite advances in understanding the genetic underpinning of many diseases, roadblocks to therapeutic development remain. The post Human Genome Project at 20 appeared first on Clinical...
The United States is spiraling. Seven-day averages for positive COVID-19 cases have exceeded 250,000 per day, having risen sharply after the Thanksgiving holiday and rising again...
MUSC Hollings Cancer Center researchers join nationwide study to examine long-term outcomes of cancer patients diagnosed with COVID-19 Credit: MUSC Hollings Cancer Center Researchers at MUSC...
Washington Post Says COVID Lab Accident "Plausible" And "Must Be Investigated" Exactly one year ago today, Zero Hedge was 'enjoying' our suspension by Twitter after we...
A new study report in Science suggests SARS-CoV-2 and its mutated new variants can evade immune responses via the selective deletion of small sections of the virus’s...
J&J said its EUA will be based on topline efficacy and safety data from the nearly 44,000-patient Phase III ENSEMBLE trial
New research suggests that SARS-CoV-2 can evade immune responses, through a recurring pattern of evolution, by selectively deleting small bits of its genetic sequence. The deletions...
Other human coronaviruses just cause the common cold, and it's possible SARS-CoV-2 may one day be the same.
Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for The post J&J asks FDA for emergency clearance...
Credit: Dr Robert Beyer Global greenhouse gas emissions over the last century have made southern China a hotspot for bat-borne coronaviruses, by driving growth of forest...